DIFFERENT KINETICS OF ANTIVIRAL AND ANTICELLULAR ACTIVITIES BETWEEN HUMAN RECOMBINANT AND NATURAL INTERFERON-GAMMA-ARISING FROM DIFFERENT RECEPTOR-BINDING PROPERTIES

被引：0
|
作者：
GOMI, K
AKINAGA, S
INOUE, A
MORIMOTO, M
NAKAMIZO, N
机构：
来源：
JAPANESE JOURNAL OF CANCER RESEARCH | 1986年 / 77卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：946 / 955
页数：10
相关论文
共 11 条
  • [1] CHARACTERISTICS OF ANTIVIRAL AND ANTICELLULAR ACTIVITIES OF HUMAN RECOMBINANT INTERFERON-GAMMA
    GOMI, K
    MORIMOTO, M
    NAKAMIZO, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1985, 76 (03): : 224 - 234
  • [2] SYNERGISTIC ANTICELLULAR AND ANTIVIRAL ACTIVITIES OF HUMAN RECOMBINANT INTERFERON-GAMMA AND INTERFERON-BETA
    GOMI, K
    KIMURA, H
    OKABE, M
    OKA, T
    MORIMOTO, M
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1986, 9 (11): : 871 - 878
  • [3] THE DIFFERENT EFFECTS OF RECOMBINANT HUMAN INTERFERON-GAMMA AND RECOMBINANT HUMAN INTERFERON-BETA ON THE ACTIVATION OF NATURAL-KILLER CELLS
    OKABE, M
    GOMI, K
    MORIMOTO, M
    NAKAMIZO, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1985, 76 (07): : 608 - 617
  • [4] DIFFERENT PHARMACOKINETICS BETWEEN NATURAL AND RECOMBINANT HUMAN INTERFERON-BETA IN RABBITS
    SATOH, YI
    KASAMA, K
    KAJITA, A
    SHIMIZU, H
    IDA, N
    JOURNAL OF INTERFERON RESEARCH, 1984, 4 (03): : 411 - 422
  • [5] THE INTERFERON-GAMMA RECEPTOR IN HUMAN-MONOCYTES IS DIFFERENT FROM THE ONE IN NONHEMATOPOIETIC CELLS
    ORCHANSKY, P
    RUBINSTEIN, M
    FISCHER, DG
    JOURNAL OF IMMUNOLOGY, 1986, 136 (01): : 169 - 173
  • [6] CHARACTERIZATION OF THE SERUM FROM A PATIENT WITH INSULIN RESISTANCE AND HYPOGLYCEMIA - EVIDENCE FOR MULTIPLE POPULATIONS OF INSULIN-RECEPTOR ANTIBODIES WITH DIFFERENT RECEPTOR-BINDING AND INSULIN-MIMICKING ACTIVITIES
    DEPIRRO, R
    ROTH, RA
    ROSSETTI, L
    GOLDFINE, ID
    DIABETES, 1984, 33 (03) : 301 - 304
  • [7] Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin
    Sokolov, A., V
    Isakova-Sivak, I. N.
    Mezhenskaya, D. A.
    Kostevich, V. A.
    Gorbunov, N. P.
    Elizarova, A. Yu
    Matyushenko, V. A.
    Berson, Yu M.
    Grudinina, N. A.
    Kolmakov, N. N.
    Zabrodskaya, Y. A.
    Komlev, A. S.
    Semak, I., V
    Budevich, A., I
    Rudenko, L. G.
    Vasilyev, V. B.
    BIOMETALS, 2023, 36 (03) : 437 - 462
  • [8] Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin
    A. V. Sokolov
    I. N. Isakova-Sivak
    D. A. Mezhenskaya
    V. A. Kostevich
    N. P. Gorbunov
    A. Yu. Elizarova
    V. A. Matyushenko
    Yu. M. Berson
    N. A. Grudinina
    N. N. Kolmakov
    Y. A. Zabrodskaya
    A. S. Komlev
    I. V. Semak
    A. I. Budevich
    L. G. Rudenko
    V. B. Vasilyev
    BioMetals, 2023, 36 : 437 - 462
  • [9] Different pharmacokinetic properties between a novel recombinant FSH (FE 999049) derived from a human cell line and follitropin alfa
    Sandstrom, R.
    Olsson, H.
    Grundemar, L.
    HUMAN REPRODUCTION, 2013, 28 : 352 - 352
  • [10] STRUCTURE-FUNCTION-RELATIONSHIPS IN THE INTERFERON-TAU (IFN-TAU) - CHANGES IN RECEPTOR-BINDING AND IN ANTIVIRAL AND ANTIPROLIFERATIVE ACTIVITIES RESULTING FROM SITE-DIRECTED MUTAGENESIS PERFORMED NEAR THE CARBOXYL-TERMINUS
    LI, JZ
    ROBERTS, RM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (40) : 24826 - 24833
12